{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:06:46Z","timestamp":1794557206198,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274276"],"award-info":[{"award-number":["82274276"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Special Support Program Projects","award":["0720240228"],"award-info":[{"award-number":["0720240228"]}]},{"name":"State and Guangdong Provincial Key Laboratory of Traditional Chinese Medicine Syndromes","award":["QZ2023ZZ32"],"award-info":[{"award-number":["QZ2023ZZ32"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-026-06310-1","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:52:12Z","timestamp":1782870732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ablation of the renal tubular gluconeogenic enzyme PCK1 drives AKI-to-CKD transition by negatively regulating the TGF-\u03b2\/Smad3 signaling pathway"],"prefix":"10.1007","volume":"83","author":[{"given":"Jing-Xuan","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Hua","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ling","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4390-0108","authenticated-orcid":false,"given":"Yue-Yu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"6310_CR1","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc11454","volume":"17","author":"JA Kellum","year":"2013","unstructured":"Kellum JA, Lameire N, KDIGO AGWG (2013) Diagnosis, evaluation, and management of acute kidney injury: a kdigo summary (part 1). Crit Care 17:204. https:\/\/doi.org\/10.1186\/cc11454","journal-title":"Crit Care"},{"key":"6310_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.kint.2020.04.020","volume":"98","author":"M Ostermann","year":"2020","unstructured":"Ostermann M, Bellomo R, Burdmann EA et al (2020) Controversies in acute kidney injury: conclusions from a kidney disease: improving global outcomes (kdigo) conference. Kidney Int 98:294\u2013309. https:\/\/doi.org\/10.1016\/j.kint.2020.04.020","journal-title":"Kidney Int"},{"key":"6310_CR3","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/S0140-6736(19)32563-2","volume":"394","author":"C Ronco","year":"2019","unstructured":"Ronco C, Bellomo R, Kellum JA (2019) Acute kidney injury. Lancet 394:1949\u20131964. https:\/\/doi.org\/10.1016\/S0140-6736(19)32563-2","journal-title":"Lancet"},{"key":"6310_CR4","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/IMNA-D-24-00027","volume":"11","author":"Y Liu","year":"2024","unstructured":"Liu Y (2024) Kidney fibrosis: fundamental questions, challenges, and perspectives. Integr Med Nephrol Androl 11:e24\u2013e27. https:\/\/doi.org\/10.1097\/IMNA-D-24-00027","journal-title":"Integr Med Nephrol Androl"},{"key":"6310_CR5","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1681\/ASN.2015010006","volume":"26","author":"MA Venkatachalam","year":"2015","unstructured":"Venkatachalam MA, Weinberg JM, Kriz W et al (2015) Failed tubule recovery, aki-ckd transition, and kidney disease progression. J Am Soc Nephrol 26:1765\u20131776. https:\/\/doi.org\/10.1681\/ASN.2015010006","journal-title":"J Am Soc Nephrol"},{"key":"6310_CR6","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1097\/IMNA-D-24-00019","volume":"11","author":"D Chen","year":"2024","unstructured":"Chen D, Guo Y, Li P (2024) New insights into a novel metabolic biomarker and therapeutic target for chronic kidney disease. Integr Med Nephrol Androl 11:e19\u2013e24. https:\/\/doi.org\/10.1097\/IMNA-D-24-00019","journal-title":"Integr Med Nephrol Androl"},{"key":"6310_CR7","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.3390\/ijms25031518","volume":"25","author":"LY Chang","year":"2024","unstructured":"Chang LY, Chao YL, Chiu CC et al (2024) Mitochondrial signaling, the mechanisms of aki-to-ckd transition and potential treatment targets. Int J Mol Sci 25:1518. https:\/\/doi.org\/10.3390\/ijms25031518","journal-title":"Int J Mol Sci"},{"key":"6310_CR8","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.1007\/s00018-021-03892-w","volume":"78","author":"Z Li","year":"2021","unstructured":"Li Z, Lu S, Li X (2021) The role of metabolic reprogramming in tubular epithelial cells during the progression of acute kidney injury. Cell Mol Life Sci 78:5731\u20135741. https:\/\/doi.org\/10.1007\/s00018-021-03892-w","journal-title":"Cell Mol Life Sci"},{"key":"6310_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.kint.2024.02.025","volume":"106","author":"LE Lee","year":"2024","unstructured":"Lee LE, Doke T, Mukhi D et al (2024) The key role of altered tubule cell lipid metabolism in kidney disease development. Kidney Int 106:24\u201334. https:\/\/doi.org\/10.1016\/j.kint.2024.02.025","journal-title":"Kidney Int"},{"key":"6310_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang HM, Ahn SH, Choi P et al (2015) Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat Med 21:37\u201346. https:\/\/doi.org\/10.1038\/nm.3762","journal-title":"Nat Med"},{"key":"6310_CR11","doi-asserted-by":"publisher","first-page":"155194","DOI":"10.1016\/j.metabol.2022.155194","volume":"131","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Hu J, Chen Z et al (2022) Transition of acute kidney injury to chronic kidney disease: role of metabolic reprogramming. Metabolism 131:155194. https:\/\/doi.org\/10.1016\/j.metabol.2022.155194","journal-title":"Metabolism"},{"key":"6310_CR12","doi-asserted-by":"publisher","first-page":"1623500","DOI":"10.3389\/fphys.2025.1623500","volume":"16","author":"M Cao","year":"2025","unstructured":"Cao M, Zhao X, Xia F et al (2025) Mitochondrial dysfunction and metabolic reprogramming in acute kidney injury: mechanisms, therapeutic advances, and clinical challenges. Front Physiol 16:1623500. https:\/\/doi.org\/10.3389\/fphys.2025.1623500","journal-title":"Front Physiol"},{"key":"6310_CR13","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1681\/ASN.2021050680","volume":"33","author":"T Verissimo","year":"2022","unstructured":"Verissimo T, Faivre A, Rinaldi A et al (2022) Decreased renal gluconeogenesis is a hallmark of chronic kidney disease. J Am Soc Nephrol 33:810\u2013827. https:\/\/doi.org\/10.1681\/ASN.2021050680","journal-title":"J Am Soc Nephrol"},{"key":"6310_CR14","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/ckj\/sfad046","volume":"16","author":"D Dalga","year":"2023","unstructured":"Dalga D, Verissimo T, de Seigneux S (2023) Gluconeogenesis in the kidney: in health and in chronic kidney disease. Clin Kidney J 16:1249\u20131257. https:\/\/doi.org\/10.1093\/ckj\/sfad046","journal-title":"Clin Kidney J"},{"key":"6310_CR15","doi-asserted-by":"publisher","first-page":"F532","DOI":"10.1152\/ajprenal.00038.2023","volume":"324","author":"T Verissimo","year":"2023","unstructured":"Verissimo T, Dalga D, Arnoux G et al (2023) Pck1 is a key regulator of metabolic and mitochondrial functions in renal tubular cells. Am J Physiol Ren Physiol 324:F532\u2013F543. https:\/\/doi.org\/10.1152\/ajprenal.00038.2023","journal-title":"Am J Physiol Ren Physiol"},{"key":"6310_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fcell.2020.00123","volume":"8","author":"YY Gu","year":"2020","unstructured":"Gu YY, Liu XS, Huang XR et al (2020) Diverse role of tgf-\u03b2 in kidney disease. Front Cell Dev Biol 8:123. https:\/\/doi.org\/10.3389\/fcell.2020.00123","journal-title":"Front Cell Dev Biol"},{"key":"6310_CR17","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-023-05769-3","volume":"619","author":"BB Lake","year":"2023","unstructured":"Lake BB, Menon R, Winfree S et al (2023) An atlas of healthy and injured cell states and niches in the human kidney. Nature 619:585\u2013594. https:\/\/doi.org\/10.1038\/s41586-023-05769-3","journal-title":"Nature"},{"key":"6310_CR18","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/ndt\/gfaa302","volume":"37","author":"D Legouis","year":"2022","unstructured":"Legouis D, Faivre A, Cipp\u00e0 PE et al (2022) Renal gluconeogenesis: an underestimated role of the kidney in systemic glucose metabolism. Nephrol Dial Transpl 37:1417\u20131425. https:\/\/doi.org\/10.1093\/ndt\/gfaa302","journal-title":"Nephrol Dial Transpl"},{"key":"6310_CR19","doi-asserted-by":"publisher","first-page":"742072","DOI":"10.3389\/fmed.2021.742072","volume":"8","author":"A Faivre","year":"2021","unstructured":"Faivre A, Verissimo T, Auwerx H et al (2021) Tubular cell glucose metabolism shift during acute and chronic injuries. Front Med (Lausanne) 8:742072. https:\/\/doi.org\/10.3389\/fmed.2021.742072","journal-title":"Front Med (Lausanne)"},{"key":"6310_CR20","doi-asserted-by":"publisher","first-page":"2508297","DOI":"10.1080\/0886022X.2025.2508297","volume":"47","author":"YY Tan","year":"2025","unstructured":"Tan YY, Wang YK, Luo XM et al (2025) Protective effect of phosphoenolpyruvate carboxykinase 1 on inflammation and fibrotic progression of iga nephropathy. Ren Fail 47:2508297. https:\/\/doi.org\/10.1080\/0886022X.2025.2508297","journal-title":"Ren Fail"},{"key":"6310_CR21","doi-asserted-by":"publisher","first-page":"47847","DOI":"10.31083\/FBL47847","volume":"31","author":"Y Wang","year":"2026","unstructured":"Wang Y, Jing Y, Yang L et al (2026) Triptolide inhibits renal fibrosis through promotion of pgc1\u03b1\/pck1-mediated renal gluconeogenesis. Front Biosci (Landmark Ed) 31:47847. https:\/\/doi.org\/10.31083\/FBL47847","journal-title":"Front Biosci (Landmark Ed)"},{"key":"6310_CR22","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.kint.2025.06.018","volume":"108","author":"D Dalga","year":"2025","unstructured":"Dalga D, Rinaldi A, Fu X et al (2025) Phosphoenolpyruvate carboxykinase 1-mediated cataplerosis is required to maintain mitochondrial fitness and to avoid kidney disease progression. Kidney Int 108:827\u2013847. https:\/\/doi.org\/10.1016\/j.kint.2025.06.018","journal-title":"Kidney Int"},{"key":"6310_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.gendis.2022.02.010","volume":"10","author":"J Xiang","year":"2023","unstructured":"Xiang J, Wang K, Tang N (2023) Pck1 dysregulation in cancer: metabolic reprogramming, oncogenic activation, and therapeutic opportunities. Genes Dis 10:101\u2013112. https:\/\/doi.org\/10.1016\/j.gendis.2022.02.010","journal-title":"Genes Dis"},{"key":"6310_CR24","doi-asserted-by":"publisher","first-page":"167674","DOI":"10.1016\/j.bbadis.2025.167674","volume":"1871","author":"R Xu","year":"2025","unstructured":"Xu R, Li J, Zhu J et al (2025) Suppression of pck1 attenuates neuronal injury and improves post-resuscitation outcomes. Biochim Biophys Acta Mol Basis Dis 1871:167674. https:\/\/doi.org\/10.1016\/j.bbadis.2025.167674","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"6310_CR25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/HEP.0000000000000716","volume":"81","author":"S Yu","year":"2025","unstructured":"Yu S, Liu X, Xu Y et al (2025) M6a-mediated gluconeogenic enzyme pck1 upregulation protects against hepatic ischemia-reperfusion injury. Hepatology 81:94\u2013110. https:\/\/doi.org\/10.1097\/HEP.0000000000000716","journal-title":"Hepatology"},{"key":"6310_CR26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.cmet.2026.01.016","volume":"38","author":"E Novoa","year":"2026","unstructured":"Novoa E, Parracho T, Inderhees J et al (2026) Lack of pck1 in hepatic stellate cells causes liver fibrosis by fueling tricarboxylic acid cycle and increasing glycolysis. Cell Metab 38:729\u2013745. https:\/\/doi.org\/10.1016\/j.cmet.2026.01.016","journal-title":"Cell Metab"},{"key":"6310_CR27","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.cmet.2024.04.015","volume":"36","author":"S Gallage","year":"2024","unstructured":"Gallage S, Ali A, Barragan Avila JE et al (2024) A 5:2 intermittent fasting regimen ameliorates nash and fibrosis and blunts hcc development via hepatic ppar\u03b1 and pck1. Cell Metab 36:1371\u20131393. https:\/\/doi.org\/10.1016\/j.cmet.2024.04.015","journal-title":"Cell Metab"},{"key":"6310_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1743-7075-2-33","volume":"2","author":"P Hakimi","year":"2005","unstructured":"Hakimi P, Johnson MT, Yang J et al (2005) Phosphoenolpyruvate carboxykinase and the critical role of cataplerosis in the control of hepatic metabolism. Nutr Metab (Lond) 2:33. https:\/\/doi.org\/10.1186\/1743-7075-2-33","journal-title":"Nutr Metab (Lond)"},{"key":"6310_CR29","doi-asserted-by":"publisher","first-page":"30409","DOI":"10.1074\/jbc.R200006200","volume":"277","author":"OE Owen","year":"2002","unstructured":"Owen OE, Kalhan SC, Hanson RW (2002) The key role of anaplerosis and cataplerosis for citric acid cycle function. J Biol Chem 277:30409\u201330412. https:\/\/doi.org\/10.1074\/jbc.R200006200","journal-title":"J Biol Chem"},{"key":"6310_CR30","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41586-020-2183-2","volume":"580","author":"D Xu","year":"2020","unstructured":"Xu D, Wang Z, Xia Y et al (2020) The gluconeogenic enzyme pck1 phosphorylates insig1\/2 for lipogenesis. Nature 580:530\u2013535. https:\/\/doi.org\/10.1038\/s41586-020-2183-2","journal-title":"Nature"},{"key":"6310_CR31","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/cac2.12084","volume":"40","author":"H Jiang","year":"2020","unstructured":"Jiang H, Zhu L, Xu D et al (2020) A newly discovered role of metabolic enzyme pck1 as a protein kinase to promote cancer lipogenesis. Cancer Commun (Lond) 40:389\u2013394. https:\/\/doi.org\/10.1002\/cac2.12084","journal-title":"Cancer Commun (Lond)"},{"key":"6310_CR32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1124\/mol.105.017483","volume":"69","author":"M Jinnin","year":"2006","unstructured":"Jinnin M, Ihn H, Tamaki K (2006) Characterization of sis3, a novel specific inhibitor of smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Mol Pharmacol 69:597\u2013607. https:\/\/doi.org\/10.1124\/mol.105.017483","journal-title":"Mol Pharmacol"},{"key":"6310_CR33","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.12659\/MSM.909236","volume":"24","author":"X Ji","year":"2018","unstructured":"Ji X, Wang H, Wu Z et al (2018) Specific inhibitor of smad3 (sis3) attenuates fibrosis, apoptosis, and inflammation in unilateral ureteral obstruction kidneys by inhibition of transforming growth factor \u03b2 (tgf-\u03b2)\/smad3 signaling. Med Sci Monit 24:1633\u20131641. https:\/\/doi.org\/10.12659\/MSM.909236","journal-title":"Med Sci Monit"},{"key":"6310_CR34","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3389\/fphar.2019.00880","volume":"10","author":"M Jiang","year":"2019","unstructured":"Jiang M, Liu K, Luo J et al (2019) Combined blockade of smad3 and jnk pathways ameliorates progressive fibrosis in folic acid nephropathy. Front Pharmacol 10:880. https:\/\/doi.org\/10.3389\/fphar.2019.00880","journal-title":"Front Pharmacol"},{"key":"6310_CR35","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nm.2144","volume":"16","author":"L Yang","year":"2010","unstructured":"Yang L, Besschetnova TY, Brooks CR et al (2010) Epithelial cell cycle arrest in g2\/m mediates kidney fibrosis after injury. Nat Med 16:535\u2013543. https:\/\/doi.org\/10.1038\/nm.2144","journal-title":"Nat Med"},{"key":"6310_CR36","doi-asserted-by":"publisher","first-page":"e166643","DOI":"10.1172\/jci.insight.166643","volume":"8","author":"S Li","year":"2023","unstructured":"Li S, Livingston MJ, Ma Z et al (2023) Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity. Jci Insight 8:e166643. https:\/\/doi.org\/10.1172\/jci.insight.166643","journal-title":"Jci Insight"},{"key":"6310_CR37","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1159\/000485781","volume":"42","author":"H Xu","year":"2017","unstructured":"Xu H, Ma Z, Lu S et al (2017) Renal resistive index as a novel indicator for renal complications in high-fat diet-fed mice. Kidney Blood Press Res 42:1128\u20131140. https:\/\/doi.org\/10.1159\/000485781","journal-title":"Kidney Blood Press Res"},{"key":"6310_CR38","doi-asserted-by":"publisher","first-page":"5922","DOI":"10.7150\/ijbs.114075","volume":"21","author":"K Liu","year":"2025","unstructured":"Liu K, Yu M, He Y et al (2025) Smad3 mediates renal fibrosis via gpx4-dependent ferroptosis. Int J Biol Sci 21:5922\u20135935. https:\/\/doi.org\/10.7150\/ijbs.114075","journal-title":"Int J Biol Sci"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-026-06310-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06310-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06310-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:02:23Z","timestamp":1789740143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-026-06310-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6310"],"URL":"https:\/\/doi.org\/10.1007\/s00018-026-06310-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9202714\/v1","asserted-by":"object"}]},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"26 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures were approved by the Animal Ethics Committee of the Guangdong Academy of Chinese Medical Sciences (Approval No. 2023113).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the final version of this manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflicts of interest, financial or otherwise, are declared by the authors.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"337"}}